Capital Flow Monitor · Sponsors · CIK 2123924
U.S. Venture Partners XIV, L.P.
1460 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025 · 650-854-9080
Pooled Investment Fund / Venture Capital Fund · Limited Partnership· inc. DELAWARE true 2026
Fit score
—
Offering
$400.0M
Sold
$0
% sold
0.0%
Investors
0
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | D ·current | 506(b) | $400.0M | $0 | 0.0% | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Dafina Toncheva — Executive Officer, Menlo Park, CA
1 other raise
- Surgical Safety Technologies Inc. $18.2M of $20.2M · 90.1%
- Richard W Lewis — Executive Officer, Menlo Park, CA
- Jonathan D Root — Executive Officer, Menlo Park, CA
-
Casey Tansey — Executive Officer, Menlo Park, CA
3 other raises
- Cagent Vascular, Inc. $24.5M of $41.0M · 59.7%
- Iantrek, Inc. $34.7M of $42.0M · 82.8%
- Neuros Medical, Inc. $56.0M of $65.0M · 86.2%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.